Shop
Faslodex Inj Imported
Faslodex Injection Imported (Fulvestrant) is a prescription medication used to treat hormone receptor-positive (HR+) advanced or metastatic breast cancer in postmenopausal women. It belongs to a class of drugs known as selective estrogen receptor degraders (SERDs), which work by blocking and degrading estrogen receptors on cancer cells, slowing their growth and spread.
Each pre-filled syringe of Faslodex contains 250mg of Fulvestrant, administered via intramuscular injection by a healthcare professional. Doctors often prescribe Faslodex as a monotherapy or in combination with other targeted therapies for patients who have experienced disease progression after endocrine therapy.
Faslodex provides an effective alternative to tamoxifen and aromatase inhibitors, especially in cases where tumors become resistant to first-line hormone treatments. Treatment schedules usually involve two injections on the first day, followed by additional doses every two weeks for the first month, and then monthly thereafter.
Patients should not attempt self-administration, as the injection requires deep intramuscular delivery in a clinical setting. Regular monitoring of liver function and treatment response is essential during therapy.
Store Faslodex syringes in a refrigerator at 2°C to 8°C. Do not freeze or shake the syringe. Keep the product away from children and direct light.
Femara (Letrazole) 2.5mg 30’s Tablet
₨ 15,000Description:
Femara Tablet is an anti-cancer medicine containing Letrozole as its active ingredient. It is used in treating advanced breast cancer in post-menopausal women.
Product Specification
| Packaging Size | 30’s Tablet |
| Brand | Femara 2.5mg |
| Composition | Letrozole |
| Manufacturer | Novartis |
| Treatment | Breast Cancer |
- Buy Femara 2.5mg Tablet imported from Turkey
- 100% Original, Reliable & Authentic Product
- Fast and Quick Delivery in all over Pakistan
- Cash on Delivery is available
Ferinject injection
₨ 25,000Ferinject Injection (Ferric Carboxymaltose) is an intravenous iron therapy used for the treatment of iron deficiency anemia (IDA), particularly in cases where oral iron supplements are ineffective or poorly tolerated. It helps replenish iron stores quickly, supporting red blood cell production and improving hemoglobin levels.
Each vial of Ferinject contains 500mg of elemental iron in a stable ferric carboxymaltose complex, designed for controlled and safe iron release into the bloodstream. It is suitable for patients with chronic kidney disease, inflammatory bowel disease, heart failure-related anemia, or heavy menstrual bleeding leading to iron deficiency.
Healthcare professionals administer Ferinject through an IV infusion or slow injection in a clinical setting. The dosage and infusion schedule depend on the patient’s body weight and the severity of iron deficiency. Ferinject allows the administration of high doses in a single session, which reduces the need for multiple infusions.
Patients usually experience improvement in symptoms like fatigue, weakness, and shortness of breath within a few weeks after treatment. Doctors will monitor iron levels and hemoglobin during the course of therapy to assess treatment response and prevent iron overload.
Store Ferinject vials at room temperature (15°C – 25°C). Do not freeze. Protect the product from light and keep it out of reach of children.
